paroxetine has been researched along with Schizophrenia in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (46.43) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 5 (17.86) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| André, M; Aouizerate, B; Boyer, L; Capdevielle, D; Chereau, I; Coulon, N; Dassing, R; Dubertret, C; Etain, B; Fond, G; Godin, O; Leboyer, M; Leignier, S; Llorca, PM; Mallet, J; Misdrahi, D; Passerieux, C; Pignon, B; Rey, R; Schorr, B; Schürhoff, F; Szoke, A; Urbach, M | 1 |
| Altamura, AC; Buoli, M; Ciappolino, V; Serati, M | 1 |
| Li, Y; Lu, X; Tao, C; Yan, W | 1 |
| Gutierrez, AM; Mohammadi, M; Weber, M | 1 |
| Dadić-Hero, E; Grahovac, T; Petranović, D; Ružić, K; Valković, T | 1 |
| Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T | 1 |
| Gurwitz, D; Morag, A; Oved, K | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Bauer, A; Godemann, F; Jockers-Scherübl, MC; Reischies, FM; Schlattmann, P; Selig, F | 1 |
| Asai, Y; Ichimiya, T; Inoue, M; Koyama, T; Kusumi, I; Sudo, Y; Suhara, T; Takahashi, Y; Takano, A; Yasuno, F | 1 |
| Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N | 1 |
| Baroni, S; Betti, L; Cassano, GB; Catena, M; Dell'Osso, B; Giannaccini, G; Lucacchini, A; Marazziti, D | 1 |
| Danos, P; Höflich, G; Kasper, S; Möller, HJ; Scholl, HP | 1 |
| Copolov, DL; Dean, B; Hill, C; Keks, N; Naylor, L; Opeskin, K; Pavey, G | 1 |
| Abi-Dargham, A; Casanova, MF; Kleinman, JE; Laruelle, M; Toti, R; Weinberger, DR | 1 |
| Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
| Copolov, DL; Dean, B; Hayes, W; Hill, C; Keks, N; Naylor, L; Opeskin, K; Pavey, G | 1 |
| Copolov, D; Dean, B; Hill, C; Keks, N; Naylor, L; Opeskin, K; Pavey, G | 1 |
| Burrows, G; Cheung, P; Crowley, K; Maguire, K; Norman, T; Schweitzer, I | 1 |
| Green, AI; Patel, JK; Salzman, C; Tsuang, MT | 1 |
| Assion, HJ; Ehrlich, M; Heinemann, F; Hermes, G | 1 |
| Anghelescu, I; Härter, S; Hiemke, C; Szegedi, A; Weigmann, H; Wetzel, H; Wiesner, J | 1 |
| Altamura, AC; Bignotti, S; Curreli, R; Pioli, R; Tura, G | 1 |
| Anghelescu, I; Hiemke, C; Schlegel, S; Szegedi, A; Weigmann, H; Wetzel, H | 1 |
| Green, AI; Patel, JK; Strous, RD; Zimmet, S | 1 |
| Ben-Shachar, D; Gibel, A; Klein, E; Modai, I; Rauchverger, B; Ritsner, M | 1 |
| Ancione, M; Avenoso, A; Facciolá, G; Madia, A; Salemi, M; Scordo, MG; Spina, E | 1 |
| Godemann, F; Jockers-Scherübl, M; Pietzcker, A | 1 |
2 review(s) available for paroxetine and Schizophrenia
| Article | Year |
|---|---|
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Humans; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2016 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
8 trial(s) available for paroxetine and Schizophrenia
| Article | Year |
|---|---|
Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Asian People; Basal Ganglia Diseases; Chromatography, Liquid; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Japan; Male; Mass Spectrometry; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Young Adult | 2012 |
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2005 |
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia | 2005 |
Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients.
Topics: Adult; Binding Sites; Bipolar Disorder; Blood Platelets; Cell Membrane; Female; Humans; Kinetics; Lymphocytes; Male; Paroxetine; Psychotic Disorders; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2006 |
Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.
Topics: Adolescent; Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Smoking | 1998 |
Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Female; Humans; Male; Paroxetine; Prospective Studies; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 1998 |
Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline.
Topics: Adult; Clozapine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychotic Disorders; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 2000 |
Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
18 other study(ies) available for paroxetine and Schizophrenia
| Article | Year |
|---|---|
3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort.
Topics: Adult; Antidepressive Agents; Female; Humans; Incidence; Lipids; Male; Metabolic Syndrome; Paroxetine; Prospective Studies; Risk Factors; Schizophrenia | 2023 |
Effect of antidepressants on spatial memory deficit induced by dizocilpine.
Topics: Animals; Antidepressive Agents; Cell Count; Citalopram; Cognition; Cognitive Dysfunction; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluvoxamine; Hippocampus; Interneurons; Male; Maze Learning; Memory Disorders; Mianserin; Mirtazapine; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Sertraline; Spatial Memory; Venlafaxine Hydrochloride | 2016 |
The risks and benefits of switching antipsychotics: a case study approach.
Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Long-Term Care; Male; Middle Aged; Olanzapine; Paroxetine; Psychotic Disorders; Risk Assessment; Schizophrenia; Thioridazine | 2009 |
Treatment strategy in schizophrenia combined with eating disorder.
Topics: Adult; Anorexia Nervosa; Antipsychotic Agents; Apathy; Benzodiazepines; Comorbidity; Cooperative Behavior; Disease Progression; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Humans; Interdisciplinary Communication; Mobility Limitation; Olanzapine; Paroxetine; Schizophrenia; Schizophrenic Psychology; Social Isolation; Vitamin B 12; Weight Loss | 2011 |
Sex differences in human lymphoblastoid cells sensitivities to antipsychotic drugs.
Topics: Anti-Inflammatory Agents; Antidepressive Agents; Antineoplastic Agents; Antipsychotic Agents; Cell Division; Cell Survival; Cells, Cultured; Cytostatic Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Resistance; Dystonic Disorders; Female; Haloperidol; Humans; Lymphocytes; Male; Paroxetine; Risperidone; Schizophrenia; Sex Characteristics; Sex Distribution | 2013 |
Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.
Topics: Adult; Antipsychotic Agents; Carbon Isotopes; Chromatography, High Pressure Liquid; Clozapine; Computer Simulation; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Fluvoxamine; Humans; Male; Paroxetine; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Time Factors | 2006 |
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
Topics: Adult; Antipsychotic Agents; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Patient Admission; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors | 1994 |
[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.
Topics: Adult; Aged; Autopsy; Carrier Proteins; Caudate Nucleus; Cerebral Cortex; Female; Frontal Lobe; Hippocampus; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Schizophrenia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Suicide | 1995 |
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.
Topics: Adult; Diagnosis, Differential; Down-Regulation; Female; Frontal Lobe; Humans; Ketanserin; Male; Middle Aged; Occipital Lobe; Paroxetine; Psychotic Disorders; Receptors, Serotonin; Schizophrenia; Suicide; Tritium | 1993 |
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |
Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
Topics: Adolescent; Adult; Aged; Brain Chemistry; Carrier Proteins; Caudate Nucleus; Female; Hippocampus; Humans; In Vitro Techniques; Ketanserin; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Middle Aged; Nerve Tissue Proteins; Paroxetine; Prefrontal Cortex; Receptors, Serotonin; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 1996 |
Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Binding, Competitive; Carrier Proteins; Female; Haloperidol; Hippocampus; Humans; Male; Membrane Glycoproteins; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Suicide; Tritium | 1996 |
Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia.
Topics: Adult; Aggression; Blood Platelets; Carrier Proteins; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Receptors, Drug; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Chronic schizophrenia: response to clozapine, risperidone, and paroxetine.
Topics: Chronic Disease; Clozapine; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Risperidone; Schizophrenia | 1997 |
[Paroxetine-induced neuroleptic malignant syndrome].
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Hematoma, Subdural; Humans; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Postoperative Complications; Schizophrenia; Schizophrenic Psychology; Suicide, Attempted | 1997 |
Depressive symptomatology during clozapine treatment: two case reports.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Clozapine; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Schizophrenia | 1998 |
Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
Topics: Antipsychotic Agents; Clozapine; Comorbidity; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Paroxetine binding in aggressive schizophrenic patients.
Topics: Adult; Aggression; Binding, Competitive; Blood Platelets; Female; Humans; Male; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2000 |